Search Within

Larry Norton

Formats
  1. Journal Article (410)
  2. Meeting Abstract (296)
  3. Book Section (21)
  4. Conference Paper (16)
  5. Editorial (8)
  6. Guidelines (3)
  7. Correspondence (2)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (760)
  2. Breast Medicine Service (760)
  3. Department of Medicine (760)
  4. Solid Tumor Oncology Division (760)
  5. Survivorship Research (393)
  6. GSK Faculty (224)

More Groups

People
  1. Clifford Hudis (293)
  2. Edi Brogi (115)
  3. Andrew Seidman (99)
  4. Sujata Patil (97)
  5. Mark Robson (90)
  6. Hannah Wen (83)

More People

Years
  1. 2025 (7)
  2. 2024 (19)
  3. 2023 (18)
  4. 2022 (16)
  5. 2021 (13)
  6. 2020 (26)

More Years

Publications
  1. Journal of Clinical Oncology (156)
  2. Cancer Research (79)
  3. Breast Cancer Research and Treatment (48)
  4. Clinical Cancer Research (30)
  5. Laboratory Investigation (26)
  6. Modern Pathology (24)

More Publications

Publishers
  1. American Society of Clinical Oncology (160)
  2. American Association for Cancer Research (124)
  3. Nature Publishing Group (76)
  4. Springer (61)
  5. Oxford University Press (50)
  6. Elsevier Inc. (48)

More Publishers

Results (760)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of letrozole in combination with bevacizumab, an anti-VEGF antibody, in patients with hormone receptor-positive metastatic breast cancer
    Meeting Abstract

    Traina, T. A.; Dickler, M. N.; Caravelli, J. F.; Yeh, B. M.; Brogi, E.; Panageas, K.; Flores, S. A.; Norton, L.; Park, J.; Hudis, C.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • A feasibility study of an aromatase inhibitor (Al), letrozole (L) and the antibody to vascular endothelial growth factor (VEGF), bevacizurnab (B), in patients (pts) with hormone receptor-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Traina, T. A.; Dickler, M. N.; Caravelli, J. F.; Yeh, B. M.; Brogi, E.; Panageas, K.; Flores, S. A.; Norton, L.; Hudis, C.; Rugo, H.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Inhibitors of Hsp90 induce the degradation of HER2 and inhibit the growth of HER2-dependent breast tumors
    Meeting Abstract

    Solit, D. B.; Basso, A.; Smith-Jones, P.; Modi, S.; Norton, L.; Larson, S.; Neckers, L.; Scher, H.; Hudis, C.; Rosen, N.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Serum peptide profiling (SPP) by mass spectrometry (MS) to identify postmenopausal women with metastatic breast cancer
    Meeting Abstract

    Smith, K. L.; Villanueva, J.; D'Andrea, G.; Moynahan, M. E.; Sklarin, N.; Norton, L.; Hudis, C.; Tempst, P.; Robson, M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Serum HER2 extracellular domain (ECD) levels and efficacy of weekly (W) or every 3-weekly (q3W) paclitaxel (P) with or without trastuzumab (T) in patients (pts) with metastatic breast cancer (MBC): CALGB 150002/9840
    Meeting Abstract

    Seidman, A. D.; Broadwater, G.; Carney, W.; Dressler, L.; Berry, D.; Norton, L.; Hudis, C.; Winer, E.; Ellis, M.; Harris, L.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Understanding racial differences in outcome from metastatic breast cancer (MBC): A pooled analysis of Cancer and Leukemia Group B (CALGB) 9342 and 9840
    Meeting Abstract

    Polite, B. N.; Cirrincione, C.; Fleming, G. F.; Berry, D. A.; Seidman, A. D.; Muss, H.; Norton, L.; Hudis, C.; Winer, E. P.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • DNA immunization against HER2/neu+ breast cancer: Evidence for a role of both antibody and T cell for optimal tumor eradication
    Meeting Abstract

    Orlandi, F.; Venanzi, F. M.; Concetti, A.; Yamauchi, J.; Wolchok, J. D.; Norton, L.; Houghton, A. N.; Gregor, P. D.
    FASEB Journal (2005)

    Fulltext@MSK | Save
  • BRCA haploinsufficiency inhuman breast tumorigenesis
    Meeting Abstract

    King, T. A.; Li, W.; Yee, C.; Gemignani, M. L.; Olvera, N.; Brogi, E.; Robson, M. E.; Offit, K.; Norton, L.; Borgen, P. I.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Association of personal and family history with decision to undergo risk-reducing salpingo-oophorectomy in BRCA mutation carriers
    Meeting Abstract

    Kauff, N. D.; Wadsworth, E.; Goldfrank, D. J.; Robson, M. E.; Lee, J.; Lafaro, K.; Aaron, S.; Norton, L.; Barakat, R. R.; Offit, K.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Effect of adjuvant chemotherapy (CRx) on the cognitive function of older patients (pts) with breast cancer (BC): Results from a prospective study
    Meeting Abstract

    Hurria, A.; Rosen, C.; Zuckerman, E.; Holland, J.; Panageas, K.; Witmer, M.; van Gorp, W.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save